Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ®)

28 May 2025

Abstract excerpt

Background/Objectives: This overview provides a comprehensive safety evaluation of the approved live-attenuated vaccine VLA1553 (IXCHIQ®) for active immunization for the prevention of disease caused by chikungunya virus (CHIKV) in clinical trials. Methods: Protocol-defined solicited systemic events (i.e., fever, arthralgia, myalgia, fatigue, and headache) and other unsolicited arthralgia-related events were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40573907
DOI: 10.3390/vaccines13060576

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ®)PMID 40573907Read ↗

The Safety and Efficacy of the Chikungunya Virus Vaccine: A Systematic Review and Meta Analysis.Semantic proximity Read ↗

Chikungunya in the Americas: Recommendations and Conclusions.Semantic proximity Read ↗

Updates on chikungunya epidemiology, clinical disease, and diagnostics.Semantic proximity Read ↗

Evolution and immunopathology of chikungunya virus informs therapeutic development.Semantic proximity Read ↗

A scoping review of published literature on chikungunya virusSemantic proximity Read ↗

Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventionsSemantic proximity Read ↗

Pathogenicity and virulence of chikungunya virusSemantic proximity Read ↗

Progress in the molecular epidemiology of chikungunya virusSemantic proximity Read ↗

Identification of immunogenic and cross-reactive chikungunya virus-specific CD4 <sup>+</sup> T cell epitopes in chronic chikungunya viral arthritic disease in humansSemantic proximity Read ↗

Chikungunya chronic disease: a systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence of chronic chikungunya and associated risks factors in the French West Indies (La Martinique): A prospective cohort study.Semantic proximity Read ↗

Chikungunya virus: host pathogen interactionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.